Lilly (LLY), Incyte's Olumiant Gets FDA Nod for Alopecia Areata
Zacks via Yahoo Finance· 3 weeks agoSome other popular JAK inhibitor medicines available are AbbVie’s ABBV Rinvoq (upadacitinib) and...
AbbVie (ABBV) Adds FDA-Issued New Warnings to Rinvoq's Label
Zacks via Yahoo Finance· 7 months agoThe FDA issued the DSC following the final review of a post-marketing study that evaluated another...
Can Pfizer Seize Share in This Multibillion-Dollar Market?
Motley Fool· 11 months agoEarlier this month, Pfizer (NYSE: PFE) announced promising top-line phase 2b/3 results in a study...
AbbVie's (ABBV) Rinvoq Gets FDA Nod for Atopic Dermatitis
Zacks via Yahoo Finance· 6 months agoAbbVie Inc. ABBV announced that the FDA has approved its promising JAK inhibitor, Rinvoq...
Eli Lilly says FDA could deny expanded use of arthritis drug for eczema
Reuters via Yahoo News· 5 months agoOlumiant, discovered by Incyte Corp and licensed to Lilly, belongs to a class of drugs called JAK...
Pfizer's Nearly $7 Billion Acquisition Of Arena Pharma Just Paid Off In A Big Way
Investor's Business Daily· 1 month agoEtrasimod could also rival big names like AbbVie's Humira and even Pfizer's own Xeljanz. "We're...
Hammerling-Hodgers: Got a beard? If you don't properly care for it, bad things can happen
Florida Today via Yahoo News· 7 months ago“For many men, a beard is important culturally, while for others, it is simply a prominent feature...